Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion. CNBC's David Faber breaks down the details.